A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia - The NASIMMUNE Study

Trial Profile

A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia - The NASIMMUNE Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Mar 2018

At a glance

  • Drugs Azithromycin (Primary) ; Influenza vaccine live attenuated (Nasovac-S) (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Acronyms NASIMMUNE
  • Most Recent Events

    • 15 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 28 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top